Role funding:

From February 1, new prescribing rules for ADHD stimulants came into force, aimed at improving access to treatment across Aotearoa.

This change expands who can evaluate, diagnose, and initiate treatment for adults with attention-deficit hyperactivity disorder.

Previously, GPs and nurses could only prescribe medication for ADHD if they had a written recommendation from a psychiatrist or pediatrician, or if a diagnosis and initial prescription had already been made.

Under the updated rules, registered specialist practitioners and nurses can now begin administering stimulants to adults aged 18 and older who have been diagnosed with ADHD, as long as they are working within their scope of practice.

Dr. Gin Russell, lead clinical advisor for Child and Adolescent Health, says people seeking an ADHD assessment don’t need to do anything special.

She says general practices remain the first port of call because local practices know what services are available in their area.

Dr. Russell says the changes are about building a stronger professional workforce and creating a better pathway for safe and thorough assessments. Although these services may not be available everywhere immediately, we can expect more treatment options to become available over time.

GPs and nurses with a special interest in ADHD may also choose to provide assessments, but these are more complex than standard appointments.

An ADHD assessment can take 1 to 2 hours and may be spread over multiple visits. Costs vary depending on service, local funding, and follow-up care.

Under the new rules, clinicians will be able to prescribe publicly funded ADHD stimulants such as methylphenidate, dexamphetamine and lisdexamfetamine.

Dr. Russell said high demand continues to cause a global shortage of ADHD drugs, but Pharmac is actively managing supply and exploring alternative options to meet growing demand.